|
|
||||||||
1Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland 21205; 2Department of Physiology and Pharmacology, 4Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Oregon 97239; and 3Department of Cell Biology and Immunology, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands
Submitted 22 December 2003 ; accepted in final form 29 January 2004
Viral infections exacerbate asthma. One of the pathways by which viruses trigger bronchoconstriction and hyperresponsiveness is by causing dysfunction of inhibitory M2 muscarinic receptors on the airway parasympathetic nerves. These receptors normally limit acetylcholine (ACh) release from the parasympathetic nerves. Loss of M2 receptor function increases ACh release, thereby increasing vagally mediated bronchoconstriction. Because viral infection causes an influx of macrophages into the lungs, we tested the role of macrophages in virus-induced airway hyperresponsiveness and M2 receptor dysfunction. Guinea pigs infected with parainfluenza virus were hyperresponsive to electrical stimulation of the vagus nerves but not to intravenous ACh, indicating that hyperresponsiveness was due to increased release of ACh from the nerves. In addition, the muscarinic agonist pilocarpine no longer inhibited vagally induced bronchoconstriction, indicating M2 receptor dysfunction. Treating animals with liposome-encapsulated dichloromethylene-diphosphonate depleted macrophages as assessed histologically. In these animals, viral infection did not cause airway hyperresponsiveness or M2 receptor dysfunction. These data suggest that macrophages mediate virus-induced M2 receptor dysfunction and airway hyperresponsiveness.
asthma; clodronate; liposomes; vagal; parasympathetic
This article has been cited by other articles:
![]() |
M. Girard, E. Israel-Assayag, and Y. Cormier Mature CD11c+ cells are enhanced in hypersensitivity pneumonitis Eur. Respir. J., September 1, 2009; 34(3): 749 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Moreno-Vinasco, N. G. Verbout, A. D. Fryer, and D. B. Jacoby Retinoic acid prevents virus-induced airway hyperreactivity and M2 receptor dysfunction via anti-inflammatory and antiviral effects Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L340 - L346. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Belmonte Cholinergic Pathways in the Lungs and Anticholinergic Therapy for Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Proskocil and A. D. Fryer {beta}2-Agonist and Anticholinergic Drugs in the Treatment of Lung Disease Proceedings of the ATS, November 1, 2005; 2(4): 305 - 310. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |